91 results on '"Sar A"'
Search Results
2. EE12 Cost of Stroke Management in Turkey
3. PRO75 PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY
4. PRO75 PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY
5. PCN301 PATIENT ACCESS TO PERSONALIZED ONCOLOGY MEDICINES IN TURKEY
6. PCN301 PATIENT ACCESS TO PERSONALIZED ONCOLOGY MEDICINES IN TURKEY
7. Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey
8. The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey: an Expert Panel Approach for Estimation of Costs
9. The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey
10. Cost-effectiveness of Aflibercept in the treatment of wet age-related Macular Degeneration in Turkey
11. Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey
12. The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey: An Expert Panel Approach for Estimation of Costs
13. Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey
14. Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey
15. Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey
16. Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)
17. The Direct Cost-Components in Pulmonary Arterial Hypertension: An Expert Panel Approach for Estimation of Costs
18. The Cost-Of-Disease (Cod) In Wet Age-Related Macular Degeneration (Wamd) In Turkey: An Expert Panel Approach for Estimation of Costs
19. Cost-effectiveness of Aflibercept in the treatment of Central Retinal Vein Occlusion in Turkey
20. Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)
21. The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey: An Expert Panel Approach for Estimation of Costs
22. Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey
23. The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey: an Expert Panel Approach for Estimation of Costs
24. The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey: an Expert Panel Approach for Estimation of Costs
25. The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey
26. The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey: An Expert Panel Approach For Estimation of Costs
27. The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey
28. The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey
29. The Cost-Of-Disease (Cod) In Wet Age-Related Macular Degeneration (Wamd) In Turkey: An Expert Panel Approach for Estimation of Costs
30. The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey: An Expert Panel Approach for Estimation of Costs
31. Cost-effectiveness of Aflibercept in the treatment of Central Retinal Vein Occlusion in Turkey
32. Cost-Effectiveness Of Riociguat For Treatment Of Patients With Inoperable Or Post-Operative Recurrent/Persistent Chronic Thromboembolic Pulmonary Hypertension (Cteph) In Turkey
33. Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey
34. Cost-effectiveness of Aflibercept in the treatment of wet age-related Macular Degeneration in Turkey
35. The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey
36. The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey: An Expert Panel Approach for Estimation of Costs
37. The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey
38. The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey: an Expert Panel Approach for Estimation of Costs
39. The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey: An Expert Panel Approach For Estimation of Costs
40. PCN97 - Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey
41. PCV69 - The Direct Cost Components in Chronic Thromboembolic Pulmonary Hypertension in Turkey: An Expert Panel Approach for Estimation of Costs
42. PCV57 - The Direct Cost-Components in Pulmonary Arterial Hypertension: An Expert Panel Approach for Estimation of Costs
43. PSS37 - Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)
44. PSS30 - Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey
45. PSS28 - Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey
46. PDB51 - The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey
47. PCN114 - The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey: an Expert Panel Approach for Estimation of Costs
48. PCN108 - The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey: an Expert Panel Approach for Estimation of Costs
49. PCN81 - Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey
50. PSS21 - Cost-effectiveness of Aflibercept in the treatment of wet age-related Macular Degeneration in Turkey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.